Teriparatide Acetate: A Breakthrough Peptide Powder for Bone Health
Discover the power of Teriparatide Acetate (CAS 52232-67-4) for effective osteoporosis treatment.
Get a Quote & SampleProduct Core Value
Teriparatide Acetate
Teriparatide Acetate, identified by CAS 52232-67-4, is a high-purity peptide powder crucial for pharmaceutical applications, particularly in the treatment of osteoporosis. This synthetic 34-peptide fragment of human parathyroid hormone (PTH) plays a vital role in bone metabolism.
- Unlock effective osteoporosis treatment with Teriparatide Acetate (CAS 52232-67-4). Our product offers a high purity of 99%, ensuring efficacy and safety for patients.
- Experience enhanced bone health through osteoblast activation. This peptide powder stimulates bone lining cells and promotes osteoblast differentiation, crucial for strengthening bone structure.
- Benefit from a synthetic 34-peptide mirroring human parathyroid hormone. Understand the biological mechanisms behind bone metabolism regulation facilitated by this key hormone fragment.
- Source high-quality peptide powder from a trusted supplier. Explore options for purchasing this vital ingredient, knowing it supports bone metabolism regulation and can be a key component in osteoporosis treatment.
Advantages Delivered
Advanced Osteoporosis Treatment
Leverage the power of Teriparatide Acetate to combat osteoporosis. As a synthetic parathyroid hormone fragment, it offers a targeted approach to bone density improvement, a key benefit for individuals with a high risk of fracture.
Stimulates Bone Formation
This peptide powder excels at activating bone lining cells and promoting osteoblast differentiation. By mimicking the action of endogenous parathyroid hormone, it actively encourages the growth of new bone tissue.
High Purity & Reliability
With a guaranteed purity of 99%, this product meets stringent pharmaceutical standards. Rely on its consistency for your formulation needs, ensuring the quality required for sensitive medical applications.
Key Applications
Osteoporosis Treatment
Teriparatide Acetate is a primary therapeutic agent for osteoporosis, particularly for postmenopausal women and individuals with gonadal failure, addressing bone density loss effectively.
Bone Metabolism Regulation
Its mechanism of action directly targets bone metabolism by modulating adenylate cyclase and protein kinase A pathways, promoting osteoblast longevity and function.
Pharmaceutical Research & Development
As a crucial peptide powder, it serves as a valuable compound in R&D for new bone-related therapies and understanding PTH signaling pathways.
High-Risk Fracture Prevention
For patients identified with a significant risk of fractures, Teriparatide Acetate provides a vital treatment option to enhance bone strength and resilience.